The recurrence score based on the 21-gene breast-cancer assay has been clinically useful in predicting a chemotherapy benefit in hormone-receptor–positive, human epidermal growth factor receptor 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback